Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Communication
  • Published:

Effect of vitamin A administered at Expanded Program on Immunization contacts on antibody response to oral polio vaccine

Abstract

Objective: Vitamin A supplementation to mothers in the postpartum period and to their infants at routine immunization contacts is being considered to reduce vitamin A deficiency in infancy. This study was conducted to determine the impact of maternal and infant vitamin A supplementation on antibody response to oral polio vaccine (OPV).

Design: Randomized, double blind, placebo-controlled trial.

Interventions: Mothers in the intervention group received 60 mg retinol equivalent (RE) vitamin A 3–4 weeks after delivery and their infants 7.5 mg RE with each OPV dose at 6, 10 and 14 weeks of age. The control group mothers and their infants received a placebo at each of these contacts.

Main outcomes: Geometric mean (GM) titer of neutralizing antibodies and proportion of children with protective titer to the three polioviruses at 26 weeks of age.

Results: Vitamin A supplementation increased the proportion of infants with protective antibody titer against poliovirus type 1 (relative risk (RR) 1.15, 95% confidence interval (CI) 1.03–1.28) and the GM antibody titer (ratio of GM 1.55, 95% CI 1.03–2.31) following immunization. The proportion of infants with protective antibody titer against poliovirus type 2 (RR 0.99, 95% CI 0.94–1.05) or type 3 (RR 1.05, 95% CI 0.96–1.15) was not significantly different in vitamin A and placebo groups. The GM antibody titer for poliovirus type 2 (ratio of GM 0.99, 95% CI 0.64–1.54) or poliovirus type 3 (ratio of GM 1.10, 95% CI 0.69–1.75) also did not differ across groups.

Conclusions: Vitamin A given to the mothers in the postpartum period and their infants with OPV did not interfere with the antibody response to any of the three polioviruses and enhanced the response to poliovirus type 1.

Sponsorship: Division of Child Health and Development, WHO, Geneva, Norwegian Universities Committee for Development and Research and Indian Council of Medical Research, Panacea Biotec Ltd, India (provided the oral polio vaccine).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Bahl R, Kumar R, Bhandari N, Kant S, Srivastava S, Bhan MK . 1999 Vitamin A administered with measles vaccine at 9 months of age does not reduce vaccine immunogenicity J. Nutr. 129: 1569–1573

    Article  CAS  Google Scholar 

  • Benn CS, Aaby P, Bale C, Olsen J, Michaelsen KF, George E, Whittle H . 1997 Randomized trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa Lancet 350: 101–105

    Article  CAS  Google Scholar 

  • Bhandari N, Bhan MK, Sazawal S . 1994 Impact of massive dose of vitamin A given to preschool children with acute diarrhoea on subsequent respiratory and diarrhoeal morbidity Br. Med. J. 309: 1404–1407

    Article  CAS  Google Scholar 

  • Bhaskaram P, Balakrishna N . 1998 Effect of administration of 200,000 IU of vitamin A to women within 24 h after delivery on response to OPV administered to the newborn Ind. J. Pediatr. 35: 217–222

    CAS  Google Scholar 

  • Bhaskaram P, Rao KV . 1997 Enhancement in seroconversion to measles vaccine with simultaneous administration of vitamin A in 9 month old Indian children Ind. J. Pediatr. 64: 503–509

    Article  CAS  Google Scholar 

  • Cantorna MT, Nashold FE, Chun TY, Hayes CE . 1995 Vitamin A down-regulation of IFN-γ synthesis in cloned mouse Th1 lymphocytes depends on the CD28 costimulatory pathway J. Immunol. 156: 2674–2679

    Google Scholar 

  • Faden H, Modlin JF, Thoms ML, McBean AM, Ferdon MB, Ogra PL . 1990 Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses J. Infect. Dis. 162: 1291–1297

    Article  CAS  Google Scholar 

  • McBean AM, Thoms ML, Albrecht P, Cuthie JC, Bernier R . 1988 Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines Am. J. Epidemiol. 128: 615–628

    Article  CAS  Google Scholar 

  • Modlin JF, Halsey NA, Thoms ML, Meschievitz CK, Patriarca PA . 1997 Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group J. Infect. Dis. 175 Suppl 1: S228–234

    Article  Google Scholar 

  • Pasatiempo AMG, Kinoshita M, Taylor CE, Ross AC . 1990 Antibody production in vitamin A-depleted rats is impaired after immunization with bacterial polysaccharide or protein antigens F.A.S.E.B. J. 4: 2518–2527

    CAS  Google Scholar 

  • Rahman MM, Mahalanabis D, Hossain S, Wahed MA, Alvarez JO, Siber GR, Thompson C, Santosham M, Fuchs GJ . 1999 Simultaneous vitamin A administration at routine immunization contact enhances antibody response to diphtheria vaccine in infants younger than six months J. Nutr. 29: 2192–2195

    Article  Google Scholar 

  • Semba RD, Muhilal Ward BJ, Griffin DE, Scott AL, Natadisastra G, West KP, Sommer A . 1993 Abnormal T-cell subset proportions in vitamin-A-deficient children Lancet 341: 5–8

    Article  CAS  Google Scholar 

  • Semba RD, Munasir Z, Beeler J, Akib A, Muhilal Audet S, Sommer A . 1995 Reduced seroconversion to measles in infants given vitamin A with measles vaccination Lancet 345: 1330–1332

    Article  CAS  Google Scholar 

  • Semba RD, Akib A, Beeler J, Munasir Z, Permaesih D, Muherdiyantiningsih Komala, Martuti S, Muhilal . 1997 Effect of vitamin A supplementation on measles vaccination in nine-month-old infants Public Health 111: 245–247

    Article  CAS  Google Scholar 

  • Semba RD, Muhilal Mohgaddam NEG, Munasir Z, Akib A, Permaesih D, Muherdiyantiningsih Osterhaus A . 1999 Integration of vitamin A supplementation with the expanded program on immunization does not affect seroconversion to oral poliovirus vaccine in infants J. Nutr. 29: 2203–2205

    Article  Google Scholar 

  • Tokuyama Y, Tokuyama H . 1996 Retinoids as Ig isotype switch modulators. The role of retinoids in directing isotype switching to IgA and IgGI (IgE) in association with IL-4 and IL-5 Cell Immunol. 170: 230–234

    Article  CAS  Google Scholar 

  • WHO/CHD Immunization linked Vitamin A supplementation Study Group . 1998 Randomized trial to assess the benefits and safety of linking vitamin A supplementation to immunization in early infancy Lancet 352: 1257–1263

    Article  Google Scholar 

  • World Health Organization . 1993 The immunological basis for immunization. Poliomyelitis WHO/EPI/GEN/93.16. Geneva: WHO

    Google Scholar 

  • World Health Organization . 1994 Using immunization contacts as the gateway to eliminating vitamin A deficiency—a policy document WHO EPI/GEN/94.9. Geneva: WHO

    Google Scholar 

  • World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine . 1995 Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia J. Infect. Dis. 171: 1097–1106

    Article  Google Scholar 

Download references

Acknowledgements

We acknowledge the help from Dr Jose Martines, WHO, Geneva. Our thanks to Mrs Kiran Bhatia for help in statistical analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to MK Bhan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bahl, R., Bhandari, N., Kant, S. et al. Effect of vitamin A administered at Expanded Program on Immunization contacts on antibody response to oral polio vaccine. Eur J Clin Nutr 56, 321–325 (2002). https://doi.org/10.1038/sj.ejcn.1601325

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ejcn.1601325

Keywords

This article is cited by

Search

Quick links